A potent inhibitor of the O-GlcNAcase enzyme that removes the modification from proteins, Thiamet G (TG), has been proposed to have potential benefits in Alzheimer’s disease. The gene discussed is OGA; the disease is early-onset autosomal dominant Alzheimer disease.